MRNA
Moderna, Inc.
NASDAQ · USHealthcareBiotechnology
$59.49-3.77%
Price as of Jul 20, 2026
MRNA valuation
Moderna, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 11.54x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.19x
- Price / sales
- 10.61x
- Price / cash flow
- -16.34x
Enterprise value
- Enterprise value
- $19.7B
- EV / sales
- 8.85x
- EV / EBITDA
- -6.83x
- EV / EBIT
- -5.77x
- Market cap
- $23.6B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.